Legend Biotech Corporatio... (LEGN)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
32.00
0.36 (1.14%)
At close: Jan 15, 2025, 10:03 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Revenue | 285.14M | 117.00M | 89.79M | 75.68M | 57.26M | 49.13M | 23.59M |
Cost of Revenue | 144.21M | 65.36M | 313.35M | 232.16M | n/a | n/a | -96.00K |
Gross Profit | 140.93M | 51.64M | -223.55M | -156.48M | 57.26M | 49.13M | 23.69M |
Operating Income | -439.49M | -455.83M | -393.02M | -313.35M | -130.87M | -1.53M | 13.78M |
Interest Income | 54.49M | 8.18M | 971.00K | 2.93M | 4.58M | 6.21M | 1K |
Pretax Income | -520.12M | -445.72M | -386.21M | -307.62M | -130.37M | -1.62M | 13.84M |
Net Income | -518.25M | -446.35M | -386.21M | -303.48M | -132.97M | -2.78M | 9.37M |
Selling & General & Admin | 200.93M | 174.05M | 149.48M | 72.72M | 32.37M | 3.93M | 1.40M |
Research & Development | 382.22M | 335.65M | 313.35M | 232.16M | 161.94M | 60.64M | 8.20M |
Other Expenses | n/a | 2.23M | -6.07M | -74.21M | -1.68M | -2.00K | n/a |
Operating Expenses | 140.93M | 509.70M | 462.83M | 304.88M | 192.63M | 64.20M | 9.60M |
Interest Expense | 21.79M | 10.80M | 900.00K | 4.21M | 223.00K | 82.00K | n/a |
Selling & Marketing Expenses | 94.16M | 93.42M | 102.54M | 49.57M | 25.62M | 1.16M | -217.00K |
Cost & Expenses | 727.36M | 575.06M | 462.83M | 304.88M | 192.63M | 64.20M | 9.81M |
Income Tax | -1.86M | 625.00K | 1K | -4.14M | 2.60M | 1.17M | 4.47M |
Shares Outstanding (Basic) | 176.08M | 159.04M | 140.85M | 118.15M | 132.01M | 100.00M | 132.01M |
Shares Outstanding (Diluted) | 176.08M | 159.04M | 140.85M | 118.15M | 132.01M | 100.21M | 132.01M |
EPS (Basic) | -2.94 | -2.81 | -2.74 | -2.57 | -1.01 | -0.03 | 0.07 |
EPS (Diluted) | -2.94 | -2.81 | -2.74 | -2.57 | -1.01 | -0.03 | 0.07 |
EBITDA | -477.87M | -416.54M | -392.38M | -294.14M | -124.89M | 149.00K | 14.06M |
Depreciation & Amortization | 20.45M | 18.39M | 13.92M | 9.93M | 5.26M | 1.68M | 217.00K |